AMASSE CAPITAL (08168): Deng Yaoji and Song Kunxiang have been appointed as independent non-executive directors.
Baoji Capital (08168) announced that Ms. Huang Zhien has submitted her resignation as an independent non-executive director due to personal matters and health issues, effective from August 19, 2026.
AMASSE CAPITAL (08168) announced that Ms. Huang Zhien has submitted her resignation as an independent non-executive director due to other personal matters and health issues, effective from August 19, 2026.
Mr. Deng Yaoki and Mr. Song Kunxiang have been appointed as independent non-executive directors, effective from August 19, 2026.
From August 19, 2026, (1) Ms. Huang will no longer serve as the Chairman of the Board Audit Committee and a member of the Remuneration Committee and the Board Nomination Committee. (2) Mr. Deng has been appointed as the Chairman of the Audit Committee and a member of the Remuneration Committee and the Nomination Committee. (3) Mr. Song has been appointed as the Chairman of the Remuneration Committee and the Nomination Committee and a member of the Audit Committee.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276): Tian Fei has been appointed as the Secretary of the Board.

Jiangsu Hengrui Pharmaceuticals (01276) plans to repurchase 1 billion to 2 billion yuan of A-shares for the A-share employee stock ownership plan.

The world's first mRNA tumor vaccine meets phase three standards, and Sidis Pharmaceuticals (01244) rises 17% as it is re-evaluated against international benchmarks.
Jiangsu Hengrui Pharmaceuticals (01276): Tian Fei has been appointed as the Secretary of the Board.

Jiangsu Hengrui Pharmaceuticals (01276) plans to repurchase 1 billion to 2 billion yuan of A-shares for the A-share employee stock ownership plan.

The world's first mRNA tumor vaccine meets phase three standards, and Sidis Pharmaceuticals (01244) rises 17% as it is re-evaluated against international benchmarks.

RECOMMEND





